Clinical TrialID 5595
(-)- Epicatechin Becker Muscular Dystrophy
NCT03236662
Becker Muscular Dystrophy
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 5595
- Evidence Id
- 5595
- Core Evidence Id
- 5595
- Source Clinical Trial Id
- 5581
- Herb2 Clinical Trial Id
- HBCT005581
- Nct Id
- NCT03236662
- Title
- (-)- Epicatechin Becker Muscular Dystrophy
- Status
- Completed
- Phase
- Phase 2
- Study Result
- Yes
- Study Condition
- Becker Muscular Dystrophy
- Study Type
- Interventional
- Study Design
- Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: (-)-Epicatechin
- Intervention Allocation
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- Male
- Age
- Adult, Older_Adult
- Enrollment
- 2
- Outcome Measure
- Plasma Follistatin, blood biomarker concentration, 48 weeks|Plasma Myostatin, blood biomarker concentration, 48 weeks|Plasma Nitrates/ SNO, blood biomarker concentration, 48 weeks|Plasma BNP, blood biomarker concentration, 48 weeks|Plasma Creatine Kinase, blood biomarker concentration, 48 weeks|Plasma MMP-9, blood biomarker concentration, 48 weeks|Plasma TNF-Alpha, blood biomarker concentration, 48 weeks|Plasma TGF-Beta, blood biomarker concentration, 48 weeks|Plasma Follistatin:Myostain Ratio, Ratio of plasma follistatin to plasma myostatin, 48 weeks
- Sponsor Collaborator
- Craig McDonald, MD|Cardero Therapeutics, Inc.
- Funded By
- OTHER
- Location
- UC Davis Medical Center, Sacramento, California, 95817, United States
- Other Id
- 767161
- Start Date
- 2016-11
- Primary Completion Date
- 2017-11
- Completion Date
- 2017-12
- First Posted
- 2017-08-02
- Results First Posted
- 2021-07-26
- Last Update Posted
- 2021-11-24
- Study Document
- Study Protocol and Statistical Analysis Plan, https://cdn.clinicaltrials.gov/large-docs/62/NCT03236662/Prot_SAP_002.pdf|Informed Consent Form, https://cdn.clinicaltrials.gov/large-docs/62/NCT03236662/ICF_001.pdf
- Study Url
- https://clinicaltrials.gov/study/NCT03236662
- Title Cn
- Title En
- (-)- Epicatechin Becker Muscular Dystrophy
- Bilingual Status
- semi_complete